1. Eickelberg O, Sommerfeld CO, Wyser C, Tamm M, Reichenberger F, Bardin PG, et al. MMP and TIMP expression pattern in pleural effusions of different origins. Am J Respir Crit Care Med. 1997. 156:1987–1992.
2. Hoheisel G, Sack U, Hui DSC, Huse K, Chan KS, Chan KK, et al. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis. Tuberculosis. 2001. 81:203–209.
3. Jin HY, Lee KS, Jin SM, Lee YC. Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion. Respir Med. 2004. 98:115–122.
4. Kotyza J, Pesek M, Puzman P, Havel D. Progelatinase B/matrix metalloproteinase-9 proenzyme as a marker of pleural inflammation. Exp Lung Res. 2004. 30:297–309.
5. Park KJ, Hwang SC, Sheen SS, Oh YJ, Han JH, Lee KB. Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer. Respiration. 2005. 72:166–175.
6. Iglesias D, Alegre J, Aleman C, Ruiz E, Soriano T, Armadans LI, et al. Metalloproteinaes and tissue inhibitors of metalloproteinase in exudative pleural effusions. Eur Respir J. 2005. 25:104–109.
7. Di Carlo A, Terracciano D, Mariano A, Macchia V. Matrix metalloproteinase-2 and matrix metalloproteinase-9 type IV collagenases in serum of patients with pleural effusions. Int J Oncol. 2005. 26:1363–1368.
8. Light RW, MacGregor MI, Luchsinger PC, Ball WC Jr. Pleural effusion: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972. 77:507–513.
9. Ocaña I, Martínez Vázquez JM, Segura RM, Fernandez de Sevilla T, Capdevila JA. Adenosine deaminase in pleural fluid: Test for diagnosis of tuberculous pleural effusion. Chest. 1983. 84:51–53.
10. Light RW, Girad WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med. 1980. 69:507–512.
11. Lee BH, Jee HS, Choi JC, Park YB, An CH, Kim JY, et al. Therapeutic effect of prednisolone in tuberculous pleurisy: a prospective study for the prevention of the pleural adhesion. Tuberc Respir Dis. 1999. 46:481–488.
12. Kyung SY, Kim YJ, Lim YH, AN CH, Lee SP, Park JW, et al. Spontaneous resolution of residual pleural thickening in tuberculous pleurisy. Tuberc Repir Dis. 2005. 59:69–76.
13. Kim YJ, Kim JH, Jeon HK, Kim MK, Jo YC, Kyung SY, et al. The expression of MMPs and TIMPs in IPF and NSIP. Tuberc Repir Dis. 2006. 61:447–455.
14. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999. 274:21491–21494.
15. Murphy G, Docherty AJ. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol. 1992. 7:120–125.
16. Chang JC, Wysocki A, Tchou-Wong KM, Moskowitz N, Zhang Y, Rom WN. Effect of Mycobacterioum tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax. 1996. 51:306–311.
17. O'Connell JP, Willenbrock F, Docherty AJ, Eaton D, Murphy G. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B. J Biol Chem. 1994. 269:14967–14973.
18. Light RW, Lee YCG. Textbook of pleural diseases. 2003. 1st ed. New York: Oxford University Press Inc..
19. Cho JH, Nam JH, Lee KH, Yoon BK, Ryu JS, Kwak SM, et al. Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 levels in exudative pleural effusions. Tuberc Respir Dis. 2005. 59:517–521.
20. Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem. 1991. 266:13070–13075.
21. Baragi VM, Fliszar CJ, Conroy MC, Ye QZ, Shipley JM, Welgus HG. Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin. J Biol Chem. 1994. 269:2692–2697.
22. Nguyen Q, Willenbrock F, Cockett MI, O'Shea M, Docherty AJ, Murphy G. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A. Biochemistry. 1994. 33:2089–2095.
23. Stetler-Stevenson WG, Krutzsch HC, Liotta LA. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem. 1989. 264:17374–17378.
24. Chesler L, Golde DW, Bersch N, Johnson MD. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. Blood. 1995. 86:4506–4515.
25. Kinoshita T, Sato H, Okada A, Ohuchi E, Imai K, Okada Y, et al. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem. 1998. 273:16098–16103.